Rheumatic Complications of Immune Checkpoint Inhibitors.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33589099.
- Also identified by DOI 10.1016/j.mcna.2020.09.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune checkpoint inhibitors activate the immune system to combat cancer. In doing so, however, they can cause immune-related adverse events (irAEs), including rheumatic syndromes, such as inflammatory arthritis, polymyalgia rheumatica, and myositis. This article reviews rheumatic irAEs that may be encountered in the general medicine practice and provides guidance to support prompt recognition, referral, and treatment of these patients.
Medical subject headings
- Immune Checkpoint Inhibitors
- Neoplasms
- Rheumatic Diseases